The challenge of subgroup analyses - Reporting without distorting

被引：400

作者：

Lagakos, SW ^{[1
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 16期

关键词：

D O I：

10.1056/NEJMp068070

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1667 / 1669

页数：3

共 5 条

[1] Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction [J].

Antman, EM ;

Morrow, DA ;

McCabe, CH ;

Murphy, SA ;

Ruda, M ;

Sadowski, Z ;

Budaj, A ;

López-Sendón, JL ;

Guneri, S ;

Jiang, F ;

White, HD ;

Fox, KAA ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14) :1477-1488

[2] Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].

Assmann, SF ;

Pocock, SJ ;

Enos, LE ;

Kasten, LE .

LANCET, 2000, 355 (9209) :1064-1069

[3]

Bailar JC., 1992, MED USES STAT

[4] Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trials [J].

Parker, AB ;

Naylor, CD .

AMERICAN HEART JOURNAL, 2000, 139 (06) :952-961

[5] ANALYSIS AND INTERPRETATION OF TREATMENT EFFECTS IN SUBGROUPS OF PATIENTS IN RANDOMIZED CLINICAL-TRIALS [J].

YUSUF, S ;

WITTES, J ;

PROBSTFIELD, J ;

TYROLER, HA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01) :93-98

← 1 →